ERBB2 and carcinoma: In this review, we evaluated the predictive and prognostic role of HER2 status (including overexpression, amplification, and mutation) in various types of carcinoma beyond breast and gastroesophageal tumors described in the most important studies in the literature, with special regard to the scoring and assays used, the clinical parameters analyzed, and therapeutic approaches.